In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: Evidence for an innate neutrophil disturbance

Journal of Innate Immunity

Volumn 2, Issue 3, 2010, Pages 260-266

  Moriceau, Sandra ^a   Lenoir, Gérard ^b   Witko Sarsat, Véronique ^a,c  

^a INSERM U845 ^*  (United States)

^b Necker Hospital   (United States)

^c INSTITUT COCHIN   (France)

Author keywords

Apoptosis; Cystic fibrosis transmembrane regulator; Diamide; Inflammation; Neutrophil; Roscovitine

Indexed keywords

DIAMIDE; LIPOCORTIN 5; ROSCOVITINE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SCHOOL CHILD;

ADOLESCENT; APOPTOSIS; BACTERIAL INFECTIONS; BENZOIC ACIDS; CASPASE 3; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIAMIDE; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; NEUTROPHILS; OXIDATION-REDUCTION; PURINES; THIAZOLIDINES;

EID: 77951497702     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000295791     Document Type: Article

References (34)

1. Cantin A: Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med 1995; 151: 939-941.
2. Nichols D, Chmiel J, Berger M: Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev Allergy Immunol 2008; 34: 146-162.
3. Witko-Sarsat V, Halbwachs-Mecarelli L, Schuster A, Nusbaum P, Ueki I, Canteloup S, Lenoir G, Descamps-Latscha B, Nadel JA: Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am J Respir Cell Mol Biol 1999; 20: 729-736.
4. Bals R, Weiner DJ, Wilson JM: The innate immune system in cystic fibrosis lung disease. J Clin Invest 1999; 103: 303-307.
5. Doring G, Gulbins E: Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 2009; 11: 208-216.
6. Downey DG, Bell SC, Elborn JS: Neutrophils in cystic fibrosis. Thorax 2009; 64: 81-88.
7. Russell KJ, McRedmond J, Mukherji N, Costello C, Keatings V, Linnane S, Henry M, Fitzgerald MX, O'Connor CM: Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med 1998; 157: 756-761.
8. Witko-Sarsat V, Halbwachs-Mecarelli L, Sermet-Gaudelus I, Bessou G, Lenoir G, Allen RC, Descamps-Latscha B: Priming of blood neutrophils in children with cystic fibrosis: correlation between functional and phenotypic expression of opsonin receptors before and after platelet-activating factor priming. J Infect Dis 1999; 179: 151-162.
9. Adib-Conquy M, Pedron T, Petit-Bertron AF, Tabary O, Corvol H, Jacquot J, Clement A, Cavaillon JM: Neutrophils in cystic fibrosis display a distinct gene expression pattern. Mol Med 2008; 14: 36-44.
10. Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, Descamps-Latscha B: Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 1996; 157: 2728-2735.
11. Sermet-Gaudelus I, Dechaux M, Vallee B, Fajac A, Girodon E, Nguyen-Khoa T, Marianovski R, Hurbain I, Bresson JL, Lenoir G, Edelman A: Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes. Am J Respir Crit Care Med 2005; 171: 1026-1031.
12. Rossi AG, Hallett JM, Sawatzky DA, Teixeira MM, Haslett C: Modulation of granulocyte apoptosis can influence the resolution of inflammation. Biochem Soc Trans 2007; 35: 288-291.
13. Hallett JM, Leitch AE, Riley NA, Duffin R, Haslett C, Rossi AG: Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation. Trends Pharmacol Sci 2008; 29: 250-257.
14. Moriceau S, Kantari C, Mocek J, Davezac N, Gabillet J, Guerrera IC, Brouillard F, Tondelier D, Sermet-Gaudelus I, Danel C, Lenoir G, Daniel S, Edelman A, Witko-Sarsat V: Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients. J Immunol 2009; 182: 7254-7263.
15. McKeon DJ, Condliffe AM, Cowburn AS, Cadwallader KC, Farahi N, Bilton D, Chilvers ER: Prolonged survival of neutrophils from patients with delta F508 CFTR mutations. Thorax 2008; 63: 660-661.
16. Dibbert B, Weber M, Nikolaizik WH, Vogt P, Schoni MH, Blaser K, Simon HU: Cytokinemediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. Proc Natl Acad Sci USA 1999; 96: 13330-13335.
17. Kantari C, Pederzoli-Ribeil M, Amir-Moazami O, Gausson-Dorey V, Moura IC, Lecomte MC, Benhamou M, Witko-Sarsat V: Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 2007; 110: 4086-4095.
18. Pardo J, Urban C, Galvez EM, Ekert PG, Muller U, Kwon-Chung J, Lobigs M, Mullbacher A, Wallich R, Borner C, Simon MM: The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol 2006; 174: 509-519.
19. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG: NF-κB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274: 4309-4318.
20. Scheel-Toellner D, Wang K, Craddock R, Webb PR, McGettrick HM, Assi LK, Parkes N, Clough LE, Gulbins E, Salmon M, Lord JM: Reactive oxygen species limit neutrophil life span by activating death receptor signaling. Blood 2004; 104: 2557-2564.
21. O'Neill AJ, O'Neill S, Hegarty NJ, Coffey RN, Gibbons N, Brady H, Fitzpatrick JM, Watson RW: Glutathione depletion-induced neutrophil apoptosis is caspase 3 dependent. Shock 2000; 14: 605-609.
22. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez- Losa M, Walker TR, Duffin R, Gray M, Crescenzi E, Martin MC, Brady HJ, Savill JS, Dransfield I, Haslett C: Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 2006; 12: 1056-1064.
23. Koedel U, Frankenberg T, Kirschnek S, Obermaier B, Häcker H, Paul R, Häcker G: Apoptosis is essential for neutrophil functional shutdown and determines tissue damage in experimental pneumococcal meningitis. PLoS Pathog 2009; 5:e1000461.
24. Painter RG, Valentine VG, Lanson NA Jr, Leidal K, Zhang Q, Lombard G, Thompson C, Viswanathan A, Nauseef WM, Wang G, Wang G: CFTR expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006; 45: 10260-10269.
25. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, Verkman AS: Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. J Clin Invest 2002; 110: 1651-1658.
26. Gottlieb RA, Dosanjh A: Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis. Proc Natl Acad Sci USA 1996; 93: 3587-3591.
27. Jungas T, Motta I, Duffieux F, Fanen P, Stoven V, Ojcius DM: Glutathione levels and Bax activation during apoptosis due to oxidative stress in cells expressing wild-type and mutant cystic fibrosis transmembrane conductance regulator. J Biol Chem 2002; 277: 27912-27918.
28. Hudson VM: Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med 2001; 30: 1440-1461.
29. Linsdell P, Hanrahan JW: Glutathione permeability of CFTR. Am J Physiol 1998; 275:C323-C326.
30. Watson RW: Redox regulation of neutrophil apoptosis. Antioxid Redox Signal 2002; 4: 97-104.
31. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB: Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 1998; 92: 4808-4818.
32. Konstan MW, Byard PJ, Hoppel CL, Davis PB: Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-854.
33. Balfour-Lynn IM, Lees B, Hall P, Phillips G, Khan M, Flather M, Elborn JS: Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis. Am J Respir Crit Care Med 2006; 173: 1356-1362.
34. Gu Y, Harley IT, Henderson LB, Aronow BJ, Vietor I, Huber LA, Harley JB, Kilpatrick JR, Langefeld CD, Williams AH, Jegga AG, Chen J, Wills-Karp M, Arshad SH, Ewart SL, Thio CL, Flick LM, Filippi MD, Grimes HL, Drumm ML, Cutting GR, Knowles MR, Karp CL: Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009; 458: 1039-1042.